Treatment, prognostic markers, and survival in thymic neuroendocrine tumors
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000007842
Abstract: Abstract Neuroendocrine tumors of the thymus (NETTs) are rare but aggressive, and lead to poor overall survival. This retrospective study was designed to analyze factors that correlate with the prognosis of patients with NETTs. From… read more here.
Keywords: treatment prognostic; carcinoma; markers survival; neuroendocrine tumors ... See more keywords
Second-line treatment and prognostic factors in neuroendocrine carcinoma.
Sign Up to like & getrecommendations! Published in 2022 at "Endocrine-related cancer"
DOI: 10.1530/erc-22-0102
Abstract: Neuroendocrine carcinomas (NEC) are aggressive malignant diseases. Etoposide-based rechallenge (EBR) and the prognostic role of Rb status in second-line chemotherapy (2L) have not been studied. The objectives of this study were to report the results… read more here.
Keywords: prognostic factors; status; line; line treatment ... See more keywords